Delivery Forum November 18 FOSTER CITY, Nov. 2 /PRNewswire/ -- Biotechnology stocks are broadly resurgent again, and the drug-delivery group is no exception. The Third Annual Informed Investors Bay Area Drug Delivery Stocks Forum on November 18 offers investors a full update on companies in this group. The Forum features companies like Aradigm (Nasdaq: ARDM) and Bioject Medical Technologies, Inc. (Nasdaq: BJCT), which are developing alternatives for conventional, needle delivery. It also gives investors a broad look at the group, from inhaleable-insulin developer Inhale Therapeutics (Nasdaq: INHL) with a market capitalization of $2.3 billion, to tiny, emulsion-delivery firm Sonus, sporting a $6 million market capitalization. The Forum runs from 8:30 a.m. to 12:30 p.m. Saturday, November 18 at the Crowne Plaza Hotel in Foster City. The cost is $25 prepaid, $40 at the door. More information and registration can be found at www.InformedInvestors.com or by calling 800-992-4683. Aradigm Corporation is a developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Aradigm's principal product development programs are based on its AERx Pulmonary Drug Delivery System, which creates aerosols from liquid drug formulations for delivery locally to the lung or systemically via the lung. Inhale, located in San Carlos, Calif., is pioneering drug delivery systems to deliver easily a range of inhaleable drugs. Inhale now has four partnered development projects that are in clinical testing. They are inhaleable forms of drugs used to treat diabetes, multiple sclerosis, osteoporosis and emphysema. Bioject Medical Technologies Inc. develops, manufactures and markets jet injection systems for needle-free drug delivery. Bioject's two core products are the Biojector 2000 and the Vitajet. The Biojector 2000 system is a CO2 cartridge that delivers doses of medication through the skin. The Vitajet serves a similar function as the Biojector, but is powered by a spring rather than CO2. InformedInvestors.com is the conduit for unfiltered communication between individual investors and the executives of technology and biotechnology companies. Live virtual and onsite Forums, special webcasts, original editorial pieces and widely followed weekly radio shows, "BioTalk" and "Tech Check," put individual investors in the analyst's chair. SOURCE InformedInvestors.com /CONTACT: Brian Finnigan or Steve Chanecka, both of InformedInvestors.com, 916-780-6100, or 800-992-4683/ /Web site: http://www.informedinvestors.com/ (INHL ARDM BJCT) CO: InformedInvestors.com; Aradigm Corporation; Bioject Medical Technologies, Inc.; Inhale Therapeutics ST: California IN: FIN MLM BIO SU:
Aradigm, Inhale, Bioject Update Investors at Annual Drug
Press spacebar to pause and continue. Press esc to stop.